Advertisement

Are risk models based on administrative registries any better than those utilizing clinical data?

  • Lorenzo Azzalini
    Correspondence
    Corresponding author at: Division of Cardiology, Department of Medicine, University of Washington Medical Center, 1959 NE Pacific St, Box 356422, Seattle, WA 98195, USA.
    Affiliations
    Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, USA
    Search for articles by this author
Published:November 01, 2022DOI:https://doi.org/10.1016/j.ijcard.2022.10.176
      Risk stratification before invasive procedures is fundamental to inform decision-making with patients and their families, and set reasonable expectations with regards to the risks of the intervention [
      • Azzalini L.
      The new PROGRESS-CTO complication scores: the peace of mind of taking a calculated risk.
      ]. This is becoming more relevant in contemporary practice, as cardiac procedures (e.g., percutaneous coronary intervention, PCI) are currently being performed in populations of increasing age and complexity.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Azzalini L.
        The new PROGRESS-CTO complication scores: the peace of mind of taking a calculated risk.
        JACC Cardiovasc. Interv. 2022; 15: 1423-1426
        • Castro-Dominguez Y.S.
        • Wang Y.
        • Minges K.E.
        • et al.
        Predicting in-hospital mortality in patients undergoing percutaneous coronary intervention.
        J. Am. Coll. Cardiol. 2021; 78: 216-229
        • Mehran R.
        • Aymong E.D.
        • Nikolsky E.
        • et al.
        A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.
        J. Am. Coll. Cardiol. 2004; 44: 1393-1399
        • Aktuerk D.
        • McNulty D.
        • Ray D.
        • et al.
        National administrative data produces an accurate and stable risk prediction model for short-term and 1-year mortality following cardiac surgery.
        Int. J. Cardiol. 2016; 203: 196-203
        • Chu Y.T.
        • Ng Y.Y.
        • Wu S.C.
        Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality.
        BMC Health Serv. Res. 2010; 10: 40
        • Azzalini L.
        • Chabot-Blanchet M.
        • Southern D.A.
        • et al.
        A disease-specific comorbidity index for predicting mortality in patients admitted to hospital with a cardiac condition.
        CMAJ. 2019; 191: E299-E307
        • Shoji S.
        • Kohsaka S.
        • Kumamaru H.
        • et al.
        Risk prediction models in patients undergoing percutaneous coronary intervention: a collaborative analysis from a Japanese administrative dataset and nationwide academic procedure registry.
        Int. J. Cardiol. 2022;
        • Iorio A.
        • Sinagra G.
        • di Lenarda A.
        Administrative database, observational research and the tower of babel.
        Int. J. Cardiol. 2019; 284: 118-119
        • Azzalini L.
        • Jolicoeur E.M.
        You have been reclassified! Challenges in creating and applying noninvasive risk models for coronary artery disease.
        Can. J. Cardiol. 2015; 31: 696-698
        • Leening M.J.G.
        • Vedder M.M.
        • Witteman J.C.M.
        • Pencina M.J.
        • Steyerberg E.W.
        Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician’s guide.
        Ann. Intern. Med. 2014; 160: 122-131